In 2012, the psychosis unit at Sahlgrenska University hospital developed a clinical assessment program with the aim of providing detailed information on patient function, quality of life and diagnosis. The assessment program was based on the program used in S:t Görans bipolar project but was adapted to fit clinical needs in psychosis care. After written consent, patient data will also be used in research. Study participants are assessed using diagnostic, neuropsychological, and neuropsychiatric methods as well as using magnetic resonance imaging and cerebrospinal fluid analysis. In order to perform genetic analysis and to secure future research, whole blood, serum, and cerebrospinal fluid samples are stored at KI Biobank. A long term aim of the research is to find biological markers to predict relapse, treatment response, side-effects, cognitive- and psychosocial function, and quality of life in individuals with a psychosis disorder.
For more information about the S:t Göran ADHD study